Klebsiella ozaenae is a gram-negative rod that has been isolated with relative frequency from patients with atrophic rhinitis. The relationship of this bacterium to the pathogenesis of atrophic rhinitis is not understood, and whether this bacterium is simply an opportunistic colonizer of the injured nose or the etiologic agent of the disease is unclear. This study was designed to investigate a potential role for bacterially produced cilloinhibition as a mechanism for the pathogenesis of atrophic rhinitis.
Get full access to this article
View all access options for this article.
References
1.
CottleMH. Nasal atrophy, atrophic rhinitis, ozena: medical and surgical treatment. J Int Coll Surg1958;29:47284.
2.
DudleyJP. Atrophic rhinitis: antibiotic treatment. Am J Otolaryngol1987;8:38790.
3.
DuguidJP. Fimbriae and adhesive properties in Klebsiella strains. J Gen Microbiol1959;21:27186.
4.
DuguidJP. The demonstration of bacterial capsules and slime. J Pathol Bact1951;63:67385.
5.
ThompsonSC. Diseases of the nose and throat.London: Cassell, 1911: 70.
6.
FergusonJL, McCaffreyTV, KernEB, MartinWJ. The effects of sinus bacteria on human ciliated nasal epithelium in vitro. Otolaryngol Head Neck Surg (in press).
7.
Van de DonkH. The influence of pH and osmotic pressure upon tracheal ciliary beat frequency as determined by a new photoelectric registration device. Rhinology1980;18:93104.
8.
MartinWJ. Neutrophils kill pulmonary endothelial cells by a hydrogen-peroxide-dependent pathway: an in vitro model of neutrophil mediated lung injury. Am Rev Respir Dis1984;130:20913.
9.
RuskinSL. A differential diagnosis and therapy of atrophic rhinitis and ozena. Arch Otolaryngol1932;15:22257.
10.
ThornellWC. Ozena: streptomycin and nitrofuazone therapy. Arch Otolaryngol1950;52:96103.
11.
SimontonKM. Streptomycin treatment of ozena. Mayo Clin Proceed1949;24:33740.
12.
OhashiY, NakaiY, ZushiK. Enhancement of ciliary action by a beta-adrenergic stimulant. Acta Otolaryngol (Stockh)1983;(Suppl 397): 4959.
